- Increase in Scope 2 emissions (though the rate of increase is lower than previous years)
- Managing waste generation across operations
- Maintaining a balance between economic growth and environmental protection
POLY MEDICURE LIMITED
Greenhouse gas emissions & sustainability report data
In its 2023-2024 reporting, POLY MEDICURE LIMITED disclosed greenhouse gas emissions of 33.96 K tCO2e (Scope 1 & 2). By scope: Scope 1: 2.32 K tCO2e; Scope 2: 33.96 K tCO2e. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
33.96 K tCO2e (Scope 1 & 2)
2023-2024
📊 Emissions by Scope (2023-2024)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 2.32 K tCO2e |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 33.96 K tCO2e |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
✅ Reported Environmental Achievements
- Reduced approx. 45 tCO2e through digital initiatives (energy saving on desktop/laptop, QR code system, paperless processes, etc.)
- approx. 13,92,089 KWH Solar Energy Produced
- approx. 6.14% HSD Saving - 30 KL by converting steam boilers with PNG & minimizing HT Line faults
- Power consumption per production unit remains steady despite a approx. 6% rise in production and the launch of two new plants
- 90% of the wastewater is being reused
- Implementation of sustainable packaging solutions using recyclable materials and reducing PVC usage
🎯 Climate & Sustainability Targets
🔭 Long-term
- Achieving carbon neutrality across global operations
🌱 ESG Focus Areas
Environmental StewardshipSocial StewardshipSustainable Business